CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cardene In 5.0% Dextrose In Plastic Container, and when can generic versions of Cardene In 5.0% Dextrose In Plastic Container launch?
Cardene In 5.0% Dextrose In Plastic Container is a drug marketed by Chiesi and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.
This drug has twenty-one patent family members in ten countries.
The generic ingredient in CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cardene In 5.0% Dextrose In Plastic Container
A generic version of CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER was approved as nicardipine hydrochloride by ANI PHARMS on October 28th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER?
- What are the global sales for CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER?
- What is Average Wholesale Price for CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER?
Summary for CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
International Patents: | 21 |
US Patents: | 4 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 55 |
Clinical Trials: | 9 |
DailyMed Link: | CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Boston Medical Center | Phase 4 |
Vanderbilt University Medical Center | Phase 2 |
National Institute of Neurological Disorders and Stroke (NINDS) | Phase 2 |
See all CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER clinical trials
Pharmacology for CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
Paragraph IV (Patent) Challenges for CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER | Injection | nicardipine hydrochloride | 2.5 mg/mL, 10 mL Ampoules | 019734 | 1 | 2006-12-27 |
US Patents and Regulatory Information for CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER is protected by four US patents.
Patents protecting CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
Pre-mixed, ready-to-use pharmaceutical compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD FOR TREATING ACUTE ELEVATIONS OF BLOOD PRESSURE IN HUMAN SUBJECT IN NEED THEREOF
Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD FOR TREATING ACUTE ELEVATIONS OF BLOOD PRESSURE IN HUMAN SUBJECT IN NEED THEREOF
Pre-mixed, ready-to-use pharmaceutical compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chiesi | CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER | nicardipine hydrochloride | INJECTABLE;INTRAVENOUS | 019734-005 | Nov 7, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chiesi | CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER | nicardipine hydrochloride | INJECTABLE;INTRAVENOUS | 019734-005 | Nov 7, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Chiesi | CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER | nicardipine hydrochloride | INJECTABLE;INTRAVENOUS | 019734-005 | Nov 7, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
See the table below for patents covering CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2649779 | COMPOSITIONS EN BOLUS IV PRE-MELANGEES PRETES A L'EMPLOI ET PROCEDES D'UTILISATION (PRE-MIXED, READY-TO-USE IV BOLUS COMPOSITIONS AND METHODS OFUSE) | ⤷ Sign Up |
Japan | S5545075 | ⤷ Sign Up | |
Mexico | 9203588 | INYECCION DE HIDROCLORURO DE NICARDIPINA. | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |